Stifel

SF

Market cap $12.7B

ST. LOUIS, April 16, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) will release its first quarter financial results before the market opens on Wednesday, April 22, 2026. The company will host a conference call to review the results at 9:30 a.m.

The Value Plus Fund gained 4.95% in the first quarter, compared with the 4.96% gain for the Russell 2000 Value Index. For small-cap tech stocks, the first quarter proved to be quite strong, in part because this group had already suffered setbacks last year and, for the most part, valuations never got out of hand. One of the biggest detractors to our strategy's performance in the quarter was Stifel Financial.

Stifel (SF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ST. LOUIS, April 09, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced that Erica Yoon has joined the firm as a Managing Director in Stifel's Equity Sales group. Based in New York, Ms.

ST. LOUIS, March 26, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for February 28, 2026, to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed.

Dan Rasmussen, Verdad Advisors, joins 'Closing Bell Overtime' with reaction to the private credit downturn.

Stifel Financial NYSE: SF recently finished one of its strongest years ever and then split its stock. Clearly, the company feels optimistic.

NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Keefe, Bruyette & Woods, Inc., a leading specialist investment bank to the financial services and fintech sectors, and a wholly owned subsidiary of Stifel Financial Corp. (NYSE: SF), announces the upcoming index rebalancing for the first quarter of 2026.

ST. LOUIS, March 12, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced that Ajay Pathak and Bill Reisner have joined the firm as Managing Directors in Stifel's Public Finance group to co-lead a differentiated healthcare practice. Both will be based in St. Louis, where they will accelerate the continued expansion of Stifel's public finance platform with a unique market offering that provides capital markets and advisory solutions for hospitals and health systems amid growing sector complexity.

WALTHAM, Mass.--(BUSINESS WIRE)--Korsana Biosciences, Inc. (“Korsana” or the “Company”), a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, today announced that Jonathan Violin, Ph.D., President and Chief Executive Officer, will present at the Stifel 2026 Virtual CNS Forum on Tuesday, March 17, 2026 at 3:00 pm ET. A live webcast of the company presentation will be available on the Company's website at www.korsana.com. A replay.